Skip to content
Research Article Open access CC BY 4.0

Secondary Erythrocytosis, a Predominant Cause of Polycythemia- Clinical and Laboratory Evaluation of Polycythemia in a Tertiary Care Center

Zunaira Aamir, Mamona Mushtaq, Sumera Sheikh

International Blood Research & Reviews · pp. 141–149 · Published 18 Dec 2023

10.9734/ibrr/2023/v14i4327

Abstract

Aims: Polycythemia refers to an increased production of red blood cells from bone marrow. It is one of the frequent reasons for a hematology consultation. The present work aimed to examine the causes, clinical manifestations, prevalence, and diverse patterns in laboratory and clinical parameters among patients with polycythemia attending our outpatient clinics at the Indus Hospital and Health Network. Study Design: The present work is retrospective observational study which included all cases of polycythemia. Place and Duration of the Study: The study was conducted at a tertiary health care center in Karachi, Pakistan during October 2019 to July 2021. Methodology: The data from the patient diagnosed with polycythemia was entered and analyzed by using SPSS version 24.0. Descriptive statistics as per the Gaussian Normality distribution (Sapiro-Wilk) were computed along with frequencies. The association where applicable was calculated via standard statistical methods with the chi square test for categorical while independent sample t-test for the continuous variables. The level of statistical significance will be set at P < 0.05. Results: During the investigated period, a total of 33 patients were diagnosed with polycythemia demonstrating a notable male predominance (82%). The majority of the patients exhibited secondary erythrocytosis (85%) with only a minority (15%) diagnosed with polycythemia vera. Of the identified cases of secondary erythrocytosis a significant proportion (46%) was observed in individuals who were smokers while other were found with hypoxic pulmonary disease, hepatitis, and chronic kidney disease. In secondary erythrocytosis 21 patients (75%) required venesection for symptom reduction, while 7 (25%) were closely monitored due to their asymptomatic status. On the contrary all cases of polycythemia vera required a comprehensive treatment approach including venesections, cytoreduction with hydroxyurea and low dose aspirin.

Erythrocytosis polycythemia vera smoking venesection

References (35)

  1. 1 Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management [DOI]
  2. 2 Haemoglobin level and its clinical impact in a cohort of patients with COPD [DOI]
  3. 3 Prognostic Value of the Hematocrit in Patients With Severe COPD Receiving Long-term Oxygen Therapy [DOI]
  4. 4 A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline [DOI]
  5. 5 Polycythemia vera: historical oversights, diagnostic details, and therapeutic views [DOI]
  6. 6 Polycythemia vera treatment algorithm 2018 [DOI]
  7. 7 Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera [DOI]
  8. 8 Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis [DOI]
  9. 9 Classification of Hepatic Venous Outflow Obstruction: Ambiguous Terminology of the Budd-Chiari Syndrome [DOI]
  10. 10 New Perspectives on Polycythemia Vera: From Diagnosis to Therapy [DOI]
  11. 11 Does untreated obstructive sleep apnea cause secondary erythrocytosis? [DOI]
  12. 12 Mean corpuscular volume, hematocrit and polycythemia [DOI]
  13. 13 Can platelets indices and blood neutrophil to lymphocyte ratio be used as predictors for diagnosis of spontaneous bacterial peritonitis in decompensated post hepatitis liver cirrhosis? [DOI]
  14. 14 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma [DOI]
  15. 15 Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review [DOI]
  16. 16 Insulin-Like Growth Factor I Plays a Role in Regulating Erythropoiesis in Patients with End-Stage Renal Disease and Erythrocytosis [DOI]
  17. 17 Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City [DOI]
  18. 18 Erythrocytosis in Patients on Long-term Hemodialysis [DOI]
  19. 19 Erythropoiesis Associated with Viral Hepatitis in End Stage Renal Disease [DOI]
  20. 20 Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis [DOI]
  21. 21 Hematologic Manifestations of Kidney Disease [DOI]
  22. 22 Polycythemia Is Rarely Caused By Obstructive Sleep Apnea [DOI]
  23. 23 Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinoma [DOI]
  24. 24 Differential cytokine network profile in polycythemia vera and secondary polycythemia [DOI]
  25. 25 Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt [DOI]
  26. 26 Red cell distribution width is an inflammatory predictor marker of contrast induced nephropathy in patients undergoing percutaneous coronary intervention [DOI]
  27. 27 Potential limitations of diagnostic standard codes to distinguish polycythemia vera and secondary erythrocytosis [DOI]
  28. 28 Idiopathic erythrocytosis in a patient on chronic hemodialysis [DOI]
  29. 29 Idiopathic Erythrocytosis in Dialysis Patients: A Case Report and Literature Review [DOI]
  30. 30 Clinical Spectrum and Complications of Polycythemia, in Patients presenting at Tertiary Care Centre at Goa.
  31. 31 Erythrocytosis associated with chronic renal disease [DOI]
  32. 32 Higher red blood cell distribution width might differentiate primary from secondary polycythemia: A pilot study [DOI]
  33. 33 Erythrocytosis after liver transplantation: The experience of a university hospital [DOI]
  34. 34 Polycythemia in hepatits C seropositive end stage renal disease patients: Role of insulin like growth factor 1 [DOI]
  35. 35 Secondary Polycythemia [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

29

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.